Peripheral Arterial Disease (PAD)
Cardiovascular·MeSH: Peripheral Arterial Disease
Prevalence
1581.5 / 100K
Incidence
164.2 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| ferumoxytol | AMAG PHARMACEUTICALS, INC. (AMAG) |
Frequently asked questions
How many drugs are in development for Peripheral Arterial Disease (PAD)?
BioSniper tracks 1 drug in development for Peripheral Arterial Disease (PAD) across 1 company.
How many clinical trials target Peripheral Arterial Disease (PAD)?
There are 1 clinical trial targeting Peripheral Arterial Disease (PAD) tracked by BioSniper.
What is the prevalence of Peripheral Arterial Disease (PAD)?
The estimated prevalence of Peripheral Arterial Disease (PAD) is approximately 1581.5 per 100,000 population.
Deep-dive into Peripheral Arterial Disease (PAD)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis